SEC Form 4 · accession 0001127602-17-002225
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Jan 19, 2017
Accepted (ET)
Jan 23, 2017 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 19, 2017 | M | 2,000 | $50.09 | A | 37,221 | D | |
| Common Stock | Jan 19, 2017 | D | 2,000 | $153.44 | D | 35,221 | D | |
| Common Stock | Jan 19, 2017 | M | 4,000 | $57.15 | A | 39,221 | D | |
| Common Stock | Jan 19, 2017 | D | 4,000 | $153.44 | D | 35,221 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF2 | $50.09 | Jan 19, 2017 | M | 2,000 | D | Sep 15, 2010 | Sep 15, 2019 | Common Stock | 2,000 | 0 | D |
| Share Tracking Award | $57.15 | Jan 19, 2017 | M | 4,000 | D | Mar 15, 2011 | Mar 15, 2020 | Common Stock | 4,000 | 58,500 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.